Optimizing the Care of Patients with Moderate-to-Severe Asthma: Minimizing Asthma Exacerbations with Biologic Therapy

Optimizing the Care of Patients with Moderate-to-Severe Asthma: Minimizing Asthma Exacerbations with Biologic Therapy is organized by Med Learning Group.

Release Date: March 11, 2022
Expiration Date: March 11, 2023

Program Overview:
This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.

Learning Objectives:
Upon the completion of this program, attendees should be able to:
• Utilize biomarkers to identify asthma phenotypes and endotypes and to personalize the selection of therapy for patients with moderate-to-severe disease
• Differentiate between uncontrolled and severe asthma and identify patients who require step-up therapy to reduce asthma exacerbations and oral corticosteroid use
• Develop evidence-based treatment plans for patients with moderate-to-severe asthma that consider exacerbation risks, comorbidities, and quality of life